An osmotic-sensitive taurine pool is localized in rat pancreatic islet cells containing glucagon and somatostatin

American Journal of Physiology

Volumn 281, Issue 6 PART 1, 2001, Pages

  Bustamante, J ^a   Lobo, M V T ^b   Alonso, F J ^b   Mukala, N T A ^a   Gine E ^a   Solis J M ^b   Tamarit Rodriguez, J ^a   Martin Del Rio R ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

aminobutyric acid release; Amino acid content; Immunocytochemistry; Insulin secretion; Taurine distribution

Indexed keywords

EID: 33747289324     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Bertrand G, Gross R, Puech R, Loubatières-Mariani M, and Bockaert J. Evidence for a glutamate receptor of the AMPA subtype which mediates insulin release from rat perfused pancreas. Br J Pharmacol 106: 354-359, 1992.
2. Best L and Benington S. Effects of sulpbonylureas on the volume-sensitive anion channel in rat pancreatic β-cells. Br J Pharmacol 125: 874-878, 1998.
3. Best L, Brown PD, and Tomlinson S. Anion fluxes, volume regulation and electrical activity in the mammalian pancreatic β-cell. Exp Physiol 82: 957-966, 1997.
4. Best L, Miley HE, and Yates AP. Activation of an anion conductance and β-cell depolarization during hypotonically induced insulin release. Exp Physiol 81: 927-933, 1996.
5. Best L, Sheader EA, and Brown PD. A volume-activated anion conductance in insulin secreting cells. Pflugers Arch-Eur J Physiol 431: 363-370, 1996.
6. Blackard WG, Kikuchi M, Rabinovitch A, and Renold AE. An effect of hyposmolarity on insulin release in vitro. Am J Physiol 228: 706-713, 1975.
7. A receptors in neuroendocrine gastropancreatic cells. Pflugers Arch-Eur J Physiol 430: 381-388, 1995.
8. Borboni P, Porzio O, Fusco A, Sesti G, Lauro R, and Marlier LN. Molecular and cellular characterization of the GABAA receptor in the rat pancreas. Mol Cell Endocrinol 103: 157-163, 1994.
9. Briel G, Gylfe E, Hellman B, and Neuhoff V. Microdetermination of free amino acids in pancreatic islets isolated from obese-hyperglycemic mice. Acta Physiol Scand 84: 247-253, 1972.
10. Bustamante J, Alonso FJ, Lobo MVT, Giné E, Tamarit-Rodriguez J, Solís JM, and Martín del Río R. Taurine levels and localization in pancreatic islets. Adv Exp Med Biol 442: 65-69, 1998.
11. Campistron G, Geffard M, and Buijis RM. Immunological approach to the detection of taurine and immunocytochemical results. J Neurochem 46: 862-868, 1986.
12. Chamberlin ME and Strange K. Anisosmotic cell volume regulation: a comparative view. Am J Physiol Cell Physiol 257: C159-C173, 1989.
13. Cherif H, Reusen B, Ahn MT, Hoet JJ, and Remacle C. Effects of taurine on the insulin secretion of rat fetal islets from dams fed a low-protein diet. J Endocrinol 159: 341-348, 1998.
14. Cherif H, Reusen B, Dahri S, Remacle C, and Hoet JJ. Stimulatory effects of taurine on insulin secretion by fetal rat islets cultured in vitro. J Endocrinol 151: 501-506, 1996.
15. Davidson HW, Rhodes CJ, and Hutton JC. Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic beta cell via two distinct site-specific endopeptidases. Nature 333: 93-96, 1988.
16. B receptors in rat hippocampal CA1 region. Brain Res 864: 298-307, 2000.
17. Del Olmo N, Galarreta M, Bustamante J, Martín del Río R, and Solís JM. Taurine-induced synaptic potentiation: role of calcium and interaction with LTP. Neuropharmacology 39: 40-54, 2000.
18. Franconi F, Bennardini F, Mattana A, Miceli M, Ciuti M, Mian M, Gironi A, Anichini R, and Seghieri G. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am J Clin Nutr 61: 1115-1119, 1995.
19. Galarreta M, Bustamante J, Martín del Río R, and Solís JM. Taurine induces a long-lasting increase of synaptic efficacy and axon excitability in the hippocampus. J Neurosci 16: 92-102, 1996.
20. Garry DJ, Sorenson RL, Elde RP, Maley BE, and Madsen A. Immunohistochemical colocalization of GABA and insulin in β-cells of rat islet. Diabetes 35: 1090-1095, 1986.
21. Gaskins HR, Baldeón ME, Selassie L, and Beverly JL. Glucose modulates γ-aminobutyric acid release from the pancreatic βTC6 cell line. J Biol Chem 270: 30286-30289, 1995.
22. Gerber JC and Hare TA. Gamma-aminobutyric acid in peripheral tissue, with emphasis on the endocrine pancreas. Presence in two species and reduction by streptozotocin. Diabetes 28: 1073-1076, 1979.
23. Gerber JC and Hare TA. GABA in peripheral tissues: presence and actions in endocrine pancreatic function. Brain Res Bull 5: 341-346, 1980.
24. Gilon P, Bertrand G, Loubatières-Mariani M, Remacle C, and Henquin JC. The influence of γ-aminobutyric acid on hormone release by the mouse and rat endocrine pancreas. Endocrinology 129: 2521-2529, 1991.
25. Goodman HO and Shihabi ZK. Supplemental taurine in diabetic rats: effects on plasma glucose and triglycerides. Biochem Med Metab Biol 43: 1-9, 1990.
26. Grant ACG, Thomson J, Zammit VA, and Shennan DB. Volume-sensitive amino acid efflux from a pancreatic β-cell line. Mol Cell Endocrinol 162: 203-210, 2000.
27. Gylfe E. Changes of free amino acids in pancreatic β-cells after starvation and substrate deprivation. Acta Endocrinol Copenh 75: 105-118, 1974.
28. Herbert V, Lau KS, Gottlieb CW, and Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25: 1375-1384, 1965.
29. Hunter WM and Greenwood FC. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194: 495-496, 1962.
30. Huxtable RJ. Physiological actions of taurine. Physiol Rev 72: 101-163, 1992.
31. Kinard TA and Satin LS. An ATP-sensitive Cl channel current that is activated by cell swelling, cAMP and glyburide in insulin-secreting cells. Diabetes 44: 1461-1466, 1995.
32. Kulakowski EC and Maturo J. Hypoglycemic properties of taurine: not mediated by enhanced insulin release. Biochem Pharmacol 33: 2835-2838, 1984.
33. Lacy PE and Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16: 35-39, 1967.
34. Lampson WG, Kramer JH, and Schaffer SW. Potentiation of the actions of insulin by taurine. Can J Physiol Pharmacol 61: 457-463, 1983.
35. Lobo MVT, Alonso FJ, and Martín del Río R. Immunohistochemical localization of taurine in the male reproductive organs of the rat. J Histochem Cytochem 48: 313-320, 2000.
36. Madsen S, Ottersen OP, and Storm-Mathisen J. Immunocytochemical visualization of taurine: neuronal localization in the rat cerebellum. Neurosci Lett 60: 255-260, 1985.
37. Madsen S, Ottersen OP, Storm-Mathisen J, and Sturman JA. Immunocyto-chemical localization of taurine: methodological aspects. In: Taurine Functional Neurochemistry, Physiology and Cardiology, edited by Pasantes-Morales H, Martin DL, Shain W, and Martín del Río R. New York: Wiley, 1990, p. 37-44.
38. Maechler P and Wollheim CB. Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis. Nature 402: 685-689, 1999.
39. Maturo J and Kulakowski EC. Taurine binding to the purified insulin receptor. Biochem Pharmacol 37: 3755-3760, 1988.
40. Meglasson MD and Matschinsky FM. Pancreatic islet glucose metabolism and regulation of insulin secretion. Diabetes Metab Rev 2: 163-214, 1986.
41. Michalik MM, Nelson J, and Erecinska M. Glutamate production in islets of Langerhans: properties of phosphate-activated glutaminase. Metabolism 41: 1319-1326, 1992.
42. Michalik MM, Nelson J, and Erecinska M. GABA production in rat islets of Langerhans. Diabetes 42: 1506-1513, 1993.
43. Miley HE, Sheader EA, Brown PD, and Best L. Glucose-induced swelling in rat pancreatic β-cells. J Physiol (Lond) 504: 191-198, 1997.
44. Nagamatsu S, Watanabe T, Nakamichi Y, Yamamura C, Tsuzuki K, and Matsushima S. α-Soluble N-ethylmaleimide-sensitive factor attachment protein is expressed in pancreatic β cells and functions in insulin but not γ-aminobutyric acid secretion. J Biol Chem 274: 8053-8060, 1999.
45. Nagelhus EA, Lehmann A, and Ottersen OP. Neuronal-glial exchange of taurine during hypo-osmotic stress: a combined immunocytochemical and biochemical analysis in rat cerebellar cortex. Neuroscience 54: 615-631, 1993.
46. Okada Y. Localization and function of GABA in the pancreatic islets. In: GABAergic Mechanisms in the Mammalian Periphery, edited by Erdö SL and Bowery NG. New York: Raven, 1986, p. 223-240.
47. Okamoto K and Sakai Y. Inhibitory actions of taurocyamine, hypotaurine, homotaurine, taurine and GABA on spike discharges of Purkinje cells, and localization of sensitive sites, in guinea pig cerebellar slices. Brain Res 206: 371-386, 1981.
48. 2+ sequestration by taurine. Biochem Pharmacol 58: 1123-1131, 1999.
49. Pasantes-Morales H and Martín del Río R. Taurine and mechanisms of cell volume regulation. In: Taurine: Functional Neurochemistry, Physiology and Cardiology, edited by Pasantes-Morales H, Martin DL, Shain W, and Martín del Río R. New York: Wiley, 1990, p. 317-328.
50. Reetz A, Solimena M, Matteoli M, Folli F, Takei K, and De Camilli P. GABA and pancreatic B-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion. EMBO J 10: 1275-1284, 1991.
51. A-receptor chloride channels. Nature 341: 233-236, 1989.
52. Satin LS and Kinard TA. Neurotransmitters and their receptors in the islets of Langerhans of the pancreas. Endocrine 8: 213-223, 1998.
53. Satoh H. Electrophysiological and electropharmacological actions of taurine on cardiac cells. Adv Exp Med Biol 403: 285-296, 1996.
54. 2+ currents in young embryonic chick cardiomyocytes. Eur J Pharmacol 231: 443-449, 1993.
55. Shi Y, Kanaani J, Menard-Rose V, Ma YH, Chang P-Y, Hanahan D, Tobin A, Grodsky G, and Baekkeskov S. Increased expression of GAD65 and GABA in pancreatic β-cells impairs first-phase insulin secretion. Am J Physiol Endocrinol Metab 279: E684-E694, 2000.
56. Smismans A, Schuit F, and Pipeleers D. Nutrient regulation of gamma-aminobutyric acid release from islet cells. Diabetologia 40: 1411-1415, 1997.
57. Solís JM, Herranz AS, Herreras O, Lerma J, and Martín del Río R. Does taurine act as an osmoregulatory substance in the rat brain? Neurosci Lett 91: 53-58, 1988.
58. Sturman JA. Taurine in development. Physiol Rev 73: 119-147, 1993.
59. Thomas-Reetz A, Hell JW, During MJ, Walch-Solimena C, Jahn R, and De Camilli P. A γ-aminobutyric acid transporter driven by a proton pump is present in synaptic-like microvesicles of pancreatic β cells. Proc Natl Acad Sci USA 90: 5317-5321, 1993.
60. Thomas-Reetz AC and De Camilli P. A role for synaptic vesicles in non-neuronal cells: clues from pancreatic cells and from chromaffin cells. FASEB J 8: 209-216, 1994.
61. Tokunaga H, Yoneda Y, and Kuriyama K. Protective actions of taurine against streptozotocin-induced hyperglycemia. Biochem Pharmacol 28: 2807-2811, 1979.
62. Tokunaga H, Yoneda Y, and Kuriyama K. Streptozotocin-induced elevation of pancreatic taurine content and suppressive effect of taurine on insulin secretion. Eur J Pharmacol 87: 237-243, 1983.
63. Weaver CD, Yao LY, Powers AC, and Verdoorn TA. Differential expression of glutamate receptors subtypes in rat pancreatic islets. J Biol Chem 271: 12977-12984, 1996.